Bacterial vaginosis primary prevention: Difference between revisions
Category |
m Bot: Removing from Primary care |
||
Line 20: | Line 20: | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Gynecology]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
Latest revision as of 20:34, 29 July 2020
Bacterial vaginosis Microchapters |
Diagnosis |
Treatment |
Case Studies |
Bacterial vaginosis primary prevention On the Web |
American Roentgen Ray Society Images of Bacterial vaginosis primary prevention |
Risk calculators and risk factors for Bacterial vaginosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
Basic effective measures for the primary prevention of bacterial vaginosis include practicing abstinent, limit the number of sex partner, avoid douching and use of condoms and estrogen-containing contraceptives.[1][2][3]
Primary Prevention
Most cases of bacterial vaginosis occur in sexually active women between the ages of 15 and 44, especially after contact with a new partner. Condoms may provide some protection. Although BV appears to be associated with sexual activity, there is no clear evidence of sexual transmission.[4] Basic effective measures for the primary prevention of bacterial vaginosis infection include:[1][2][3]
- Be abstinent
- Use condoms
- Limit the number of sex partners
- Do not douche
- Use of estrogen-containing contraceptives
References
- ↑ 1.0 1.1 Ness RB, Hillier SL, Richter HE, Soper DE, Stamm C, McGregor J; et al. (2002). "Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina". Obstet Gynecol. 100 (4): 765. PMID 12383547.
- ↑ 2.0 2.1 Bradshaw CS, Walker SM, Vodstrcil LA, Bilardi JE, Law M, Hocking JS; et al. (2014). "The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study". J Infect Dis. 209 (10): 1562–72. doi:10.1093/infdis/jit664. PMID 24285846.
- ↑ 3.0 3.1 Bradshaw CS, Vodstrcil LA, Hocking JS, Law M, Pirotta M, Garland SM; et al. (2013). "Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use". Clin Infect Dis. 56 (6): 777–86. doi:10.1093/cid/cis1030. PMID 23243173.
- ↑ Bradshaw CS, Morton AN, Hocking J; et al. (2006). "High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence". J Infect Dis. 193 (11): 1478&ndash, 86.